Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Most Shorted Stocks
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Investors
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Careers
Contact Us
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
MCP for Agents
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Most Shorted Stocks
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Center
Investors
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
RVMD
Stock Latest News
The Fly
Revolution Medicines gets orphan designation for pancreatic cancer treatment
5d ago
RVMD
Premium
The Fly
Revolution Medicines granted Breakthrough Therapy Designation to Rasonque by FDA
6d ago
RVMD
Premium
The Fly
Revolution Medicines initiated with an Overweight at Morgan Stanley
11d ago
RVMD
Premium
The Fly
Revolution Medicines price target raised to $230 from $215 at Stifel
12d ago
RVMD
Premium
Ratings
Buy Rating Reiterated on Daraxonrasib Strength, RASolve 301 Upsizing, and Unchanged $315 Price Target
18d ago
RVMD
Premium
The Fly
NEJM publishes Phase 1/2 clinical data on daraxonrasib
18d ago
RVMD
Premium
Company Announcements
Revolution Medicines Signs Long-Term Headquarters Lease Agreement
20d ago
8K
RVMD
Premium
The Fly
Revolution Medicines price target raised to $275 from $240 at Needham
21d ago
RVMD
Premium
Ratings
Ami Fadia Raises RVMD Price Target to $275 on Strong Rasonque U.S. Launch Economics and Robust Oncology Pipeline
21d ago
RVMD
Premium
The Fly
Revolution Medicines price target raised to $265 from $220 at UBS
24d ago
RVMD
Premium
The Fly
Revolution Medicines price target raised to $275 from $240 at Guggenheim
24d ago
RVMD
Premium
Market News
Revolution Medicines Stock (RVMD) Gets Price Target Hike on New Revenue-Generating Cancer Drug
25d ago
RVMD
Premium
The Fly
Revolution Medicines price target raised to $246 from $227 at JPMorgan
25d ago
RVMD
Premium
The Fly
Revolution Medicines price target raised to $251 from $203 at RBC Capital
25d ago
RVMD
Premium
The Fly
Revolution Medicines price target raised to $248 from $230 at Raymond James
25d ago
RVMD
Premium
The Fly
Revolution Medicines price target raised to $260 from $230 at Oppenheimer
25d ago
RVMD
Premium
The Fly
Revolution Medicines price target raised to $320 from $230 at Evercore ISI
25d ago
RVMD
Premium
The Fly
Revolution Medicines price target raised to $280 from $195 at H.C. Wainwright
25d ago
RVMD
Premium
Ratings
Revolution Medicines: Buy Rating Reiterated as FDA Approval and Strong Prelaunch Demand Support Unchanged $225 Price Target
25d ago
RVMD
Premium
Ratings
Revolution Medicines Earns Buy as RASONQUE FDA Approval and Strong Pricing Outlook Drive Price Target Increase to $315
25d ago
RVMD
Premium
Company Announcements
Revolution Medicines Wins FDA Approval for RASONQUE Therapy
25d ago
8K
RVMD
Premium
The Fly
Revolution Medicines prices Rasonque at $39,800 for 30-day supply
26d ago
RVMD
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.
